서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 13 of 13

Issue DateTitle / Author(s) / CitationFileAltmetrics
2011-01
Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01)
DOI
2012-05
Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy?
DOI
2013-03
Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors
DOI
2014-07
Low Adherence to Upfront and Extended Adjuvant Letrozole Therapy among Early Breast Cancer Patients in a Clinical Practice Setting
DOI
2014-11
Factors Associated With Bone Mineral Density and Risk of Fall in Korean Adults With Type 2 Diabetes Mellitus Aged 50 Years and Older

Lee, Kyoung Min; Chung, Chin Youb; Kwon, Soon-Sun; Lee, Seung Yeol; Kim, Tae Gyun; Choi, Young; Park, Moon Seok

Journal of Clinical Endocrinology and Metabolism, Vol.99 No.11, pp.4206-4213

DOI
2015-07
Gender- and body-site-specific factors associated with bone mineral density in a non-institutionalized Korean population aged ≥50 years

Lee, Kyoung Min; Kwon, Soon-Sun; Chung, Chin Youb; Lee, Seung Yeol; Kim, Tae Gyun; Choi, Young; Park, Moon Seok

Journal of Bone and Mineral Metabolism, Vol.33 No.4, pp.401-409

DOI
2016-07
Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer
view fileDOI
2018-07
Effects of epidural steroid injections on bone mineral density and bone turnover markers in patients taking anti-osteoporotic medications

Nah, Seon Yoon; Lee, Jae Hyup; Lee, Ji-Ho

Pain Physician, Vol.21 No.4, pp.E435-E447

view file
2018-08
A first-in-human study of the new oral selective estrogen receptor degrader AZD9496 for ER+/HER2- advanced breast cancer
DOI
2018-08
Peripheral DXA measurement around ankle joint to diagnose osteoporosis as assessed by central DXA measurement
DOI
2018-11
Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study)
DOI
2022-05
Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection
DOI
2023-05
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR+/HER2-early breast cancer
DOI
1